|

Nicotine replacement Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Ottawa Heart Institute Research Corporation1

Indications

  • Tobacco Dependence1
  • Nicotine Addiction1
  • Diabetes1
  • Diabetes Mellitus, Type 21

Other1 trial

Semaglutide for Smoking Cessation in Patients With Diabetes
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.